Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) was up 2.9% during trading on Wednesday . The stock traded as high as $1.07 and last traded at $1.06. 302,491 shares changed hands during mid-day trading, an increase of 351% from the average daily volume of 67,097 shares. The stock had previously closed at $1.03.
Cardiol Therapeutics Trading Up 2.9%
The firm’s 50 day simple moving average is $1.23 and its 200-day simple moving average is $1.13.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Read More
- Five stocks we like better than Cardiol Therapeutics
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
